FILE:AGN/AGN-8K-20070104150402.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
Table of Contents
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
Table of Contents
Item 8.01. Other Events.
     On January 2, 2007, Allergan, Inc. ("Allergan") consummated the acquisition of all of the outstanding capital stock of Groupe Cornal Laboratoires and its subsidiaries ("Cornal") pursuant to a Stock Sale and Purchase Agreement ("Purchase Agreement") dated October 31, 2006, by and among Allergan and Allergan Holdings France, SAS, an indirect wholly owned subsidiary of Allergan, on the one hand, and Waldemar Kita, the controlling stockholder of Cornal, the European Pre-Floatation Fund II and the other minority stockholders of Cornal, on the other hand.
     Under the Purchase Agreement, Allergan purchased the outstanding capital stock of Cornal for an aggregate purchase price of EUR 177,200,219, or approximately $US 233,948,411, subject to possible post-closing adjustments based on a final determination of Cornal's debt and cash levels.
     The foregoing description of the Purchase Agreement and the transactions consummated thereby is qualified in its entirety by reference to the Purchase Agreement attached as Exhibit 10.1 to Allergan's Current Report on Form 8-K filed November 2, 2006.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
.
Table of Contents
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Table of Contents


